In:
Journal of Diabetes, Wiley, Vol. 11, No. 3 ( 2019-03), p. 204-213
Abstract:
Highlights Zotarolimus‐eluting stents (ZES) demonstrated good performance in the Chinese diabetic population. This single‐arm study with a performance goal design revealed an acceptable rate of events, including cardiac death, revascularization and stent thrombosis, in Chinese diabetic patients receiving ZES. Moreover, ZES may have further utility in patients with poor glucose control, complex lesions, and unfavorable clinical features.
Type of Medium:
Online Resource
ISSN:
1753-0393
,
1753-0407
DOI:
10.1111/jdb.2019.11.issue-3
DOI:
10.1111/1753-0407.12832
Language:
English
Publisher:
Wiley
Publication Date:
2019
detail.hit.zdb_id:
2485432-3
Bookmarklink